Trials / Unknown
UnknownNCT04655794
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The treatment of latent TB with 3HP is an important issue for the prevention of active TB. However, significant proportion of subjects receiving 3HP had adverse reaction. The main purpose of this observation study is to identify subjects who have higher risk to develop adverse reaction. Clinical characteristics and biomarker will be used to predict adverse reaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 3HP | all patients taking 3HP under directly observed preventive therapy (DOPT) program |
Timeline
- Start date
- 2018-04-19
- Primary completion
- 2020-11-20
- Completion
- 2021-02-12
- First posted
- 2020-12-07
- Last updated
- 2020-12-07
Locations
1 site across 1 country: Taiwan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04655794. Inclusion in this directory is not an endorsement.